ST8Sia VI Antibodies

Santa Cruz Biotechnology provides a broad selection of ST8Sia VI monoclonal antibodies for investigating this important sialyltransferase. ST8Sia VI monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ST8Sia VI, also known as ST8Sia IV or ST8Sia, plays an essential role in the biosynthesis of polysialic acid, significantly impacting cell adhesion, migration, and neural development. ST8Sia VI is particularly significant in neuronal plasticity and has been linked to various neurological disorders. Research focusing on ST8Sia VI continues to reveal new insights into cellular processes and potential therapeutic approaches. Understanding ST8Sia VI function advances knowledge in neuroscience and cell biology. Investigating ST8Sia VI expression patterns helps identify its role in both normal development and disease states. ST8Sia VI monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to make meaningful contributions to neuroscience and cellular biology research.